Difference between revisions of "Team:San Andres"
(40 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
</head> | </head> | ||
<body> | <body> | ||
− | <meta content="text/html; charset= | + | <title><endnote><head> |
− | http-equiv="content-type"> | + | <title><endnote><head> |
+ | <meta> <title> | ||
+ | </title> | ||
+ | <title>wiki</title> | ||
+ | <meta http-equiv="Content-Type" | ||
+ | content="text/html; charset=utf-8"> | ||
+ | <meta name="generator" | ||
+ | content="Google Web Designer 1.3.2.0521"> | ||
+ | <style type="text/css"> | ||
+ | html, body { | ||
+ | width: 100%; | ||
+ | height: 100%; | ||
+ | margin: 0px; | ||
+ | } | ||
+ | body { | ||
+ | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | background-image: url(https://static.igem.org/mediawiki/2015/8/8a/BBD7.jpg); | ||
+ | background-color: rgb(198, 169, 117); | ||
+ | } | ||
+ | </style> | ||
+ | <meta http-equiv="content-type" | ||
+ | content="text/html; charset=ISO-8859-1"> | ||
<title></title> | <title></title> | ||
− | <meta content="text/html; charset=ISO-8859-1 | + | <meta http-equiv="content-type" |
− | + | content="text/html; charset=ISO-8859-1"> | |
<title></title> | <title></title> | ||
− | <meta content="text/html; charset=ISO-8859-1 | + | <meta http-equiv="content-type" |
− | + | content="text/html; charset=ISO-8859-1"> | |
<title></title> | <title></title> | ||
− | <meta content="text/html; charset= | + | <title>wiki</title> |
− | http-equiv="content-type"> | + | <meta http-equiv="Content-Type" |
+ | content="text/html; charset=utf-8"> | ||
+ | <meta name="generator" | ||
+ | content="Google Web Designer 1.3.2.0521"> | ||
+ | <style type="text/css"> | ||
+ | html, body { | ||
+ | width: 100%; | ||
+ | height: 100%; | ||
+ | margin: 0px; | ||
+ | } | ||
+ | body { | ||
+ | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | </style> | ||
+ | <meta http-equiv="content-type" | ||
+ | content="text/html; charset=ISO-8859-1"> | ||
<title></title> | <title></title> | ||
− | <meta content="text/html; charset=ISO-8859-1 | + | <meta http-equiv="content-type" |
− | + | content="text/html; charset=ISO-8859-1"> | |
<title></title> | <title></title> | ||
− | <meta content="text/html; charset=ISO-8859-1" | + | <meta http-equiv="content-type" |
− | http-equiv="content-type"> | + | content="text/html; charset=ISO-8859-1"> |
+ | <title></title> | ||
+ | <meta http-equiv="content-type" | ||
+ | content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" | ||
+ | content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" | ||
+ | content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" | ||
+ | content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" | ||
+ | content="text/html; charset=ISO-8859-1"> | ||
<title></title> | <title></title> | ||
<title>exp</title> | <title>exp</title> | ||
Line 114: | Line 168: | ||
-webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
− | |||
− | |||
} | } | ||
</style> | </style> | ||
Line 529: | Line 581: | ||
-webkit-animation-timing-function: linear; | -webkit-animation-timing-function: linear; | ||
} | } | ||
+ | } | ||
+ | .gwd-a-3xpx { | ||
+ | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | } | ||
+ | .gwd-img-n53q { | ||
+ | position: absolute; | ||
+ | width: 123px; | ||
+ | left: -161.35px; | ||
+ | top: 218px; | ||
+ | } | ||
+ | .gwd-img-kryd { | ||
+ | position: absolute; | ||
+ | left: 1009.61157635431px; | ||
+ | top: 221.560837438423px; | ||
+ | width: 250px; | ||
+ | } | ||
+ | .gwd-img-ia0j { | ||
+ | position: absolute; | ||
+ | width: 135px; | ||
+ | left: -166.263300492612px; | ||
+ | top: 394.466009852218px; | ||
+ | } | ||
+ | .gwd-a-36ww { | ||
+ | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, -16.1, 0.05, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | } | ||
+ | .gwd-body-kwce { | ||
+ | width: 100%; | ||
+ | } | ||
+ | .gwd-img-5ywk { | ||
+ | position: absolute; | ||
+ | left: 990.561576354683px; | ||
+ | top: 349.384236453212px; | ||
+ | width: 250px; | ||
+ | } | ||
+ | .gwd-img-zpsn { | ||
+ | position: absolute; | ||
+ | width: 150px; | ||
+ | left: -165.73913043478px; | ||
+ | top: 49.3260869565235px; | ||
+ | } | ||
+ | .gwd-a-d01x { | ||
+ | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | } | ||
+ | .gwd-table-10nh { | ||
+ | -webkit-transform: translate3d(0px, -2px, 0px); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | } | ||
+ | .gwd-table-15ao { | ||
+ | -webkit-transform: translate3d(0px, -2px, 0px); | ||
+ | -webkit-transform-style: preserve-3d; | ||
} | } | ||
</style><!--navigation menu --> | </style><!--navigation menu --> | ||
+ | <br> | ||
<table style="width: 968px; height: 34px;" | <table style="width: 968px; height: 34px;" | ||
− | class="gwd-table-nb4m editable"> | + | class="gwd-table-nb4m editable gwd-table-15ao"> |
<tbody> | <tbody> | ||
<tr heigth="15px"> | <tr heigth="15px"> | ||
</tr> | </tr> | ||
<tr heigth="75px"> | <tr heigth="75px"> | ||
− | <td style="border: | + | <td style="border: 3px solid rgb(29, 16, 3);" |
− | onmouseout="this.bgColor='# | + | onmouseout="this.bgColor='#ffee1b'" |
− | onmouseover="this.bgColor='# | + | onmouseover="this.bgColor='#6bb402'" align="center" |
− | bgcolor="# | + | bgcolor="#ffee1b" height="30"> |
<a href="https://2015.igem.org/Team:San_Andres" | <a href="https://2015.igem.org/Team:San_Andres" | ||
style="color: rgb(0, 0, 0);">Home </a> </td> | style="color: rgb(0, 0, 0);">Home </a> </td> | ||
− | <td style="border: | + | <td style="border: 3px solid black;" |
− | onmouseout="this.bgColor='# | + | onmouseout="this.bgColor='#ffee1b'" |
− | onmouseover="this.bgColor='# | + | onmouseover="this.bgColor='#6bb402'" align="center" |
− | bgcolor="# | + | bgcolor="#ffee1b" height="30"> |
<a href="https://2015.igem.org/Team:San_Andres/Team" | <a href="https://2015.igem.org/Team:San_Andres/Team" | ||
style="color: rgb(0, 0, 0);"> Team</a> | style="color: rgb(0, 0, 0);"> Team</a> | ||
</td> | </td> | ||
− | <td style="border: | + | <td style="border: 3px solid rgb(29, 16, 3);" |
− | + | onmouseout="this.bgColor='#ffee1b'" | |
− | + | onmouseover="this.bgColor='#6bb402'" align="center" | |
− | + | bgcolor="#ffee1b" height="30"> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | onmouseout="this.bgColor='# | + | |
− | onmouseover="this.bgColor='# | + | |
− | bgcolor="# | + | |
<a href="https://2015.igem.org/Team:San_Andres/Description" | <a href="https://2015.igem.org/Team:San_Andres/Description" | ||
− | style="color: rgb(0, 0, 0);"> Project </a> | + | style="color: rgb(0, 0, 0);"> Project</a> |
</td> | </td> | ||
− | <td style="border: | + | <td style="border: 3px solid rgb(29, 16, 3);" |
− | onmouseout="this.bgColor='# | + | onmouseout="this.bgColor='#ffee1b'" |
− | onmouseover="this.bgColor='# | + | onmouseover="this.bgColor='#6bb402'" align="center" |
− | bgcolor="# | + | bgcolor="#ffee1b" height="30"> |
<a href="https://2015.igem.org/Team:San_Andres/Parts" | <a href="https://2015.igem.org/Team:San_Andres/Parts" | ||
style="color: rgb(0, 0, 0);"> Parts</a> | style="color: rgb(0, 0, 0);"> Parts</a> | ||
</td> | </td> | ||
− | < | + | <td style="border: 3px solid rgb(29, 16, 3);" |
+ | onmouseout="this.bgColor='#ffee1b'" | ||
+ | onmouseover="this.bgColor='#6bb402'" align="center" | ||
+ | bgcolor="#ffee1b" height="30"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Modeling" | ||
+ | style="color: rgb(0, 0, 0);"> Modeling</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid rgb(29, 16, 3);" | ||
+ | onmouseout="this.bgColor='#ffee1b'" | ||
+ | onmouseover="this.bgColor='#6bb402'" align="center" | ||
+ | bgcolor="#ffee1b" height="30"><a | ||
+ | href="https://2015.igem.org/Team:San_Andres/Results" | ||
+ | style="color: rgb(0, 0, 0);"> Results</a> | ||
+ | </td> | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
</table> | </table> | ||
<table style="width: 968px; height: 34px;" | <table style="width: 968px; height: 34px;" | ||
− | class="gwd-table-nb4m editable"> | + | class="gwd-table-nb4m editable gwd-table-10nh"> |
<tbody> | <tbody> | ||
<tr heigth="15px"> | <tr heigth="15px"> | ||
</tr> | </tr> | ||
<tr heigth="75px"> | <tr heigth="75px"> | ||
− | <td style="border: | + | <td style="border: 3px solid rgb(29, 16, 3);" |
− | onmouseout="this.bgColor='# | + | onmouseout="this.bgColor='#ffee1b'" |
− | onmouseover="this.bgColor='# | + | onmouseover="this.bgColor='#6bb402'" align="center" |
− | bgcolor="# | + | bgcolor="#ffee1b" height="30"> |
− | <a href="https://2015.igem.org/Team:San_Andres/ | + | <a href="https://2015.igem.org/Team:San_Andres/Notebook" |
− | style="color: rgb(0, 0, 0);"> | + | style="color: rgb(0, 0, 0);">Notebook</a> |
− | <td style="border: | + | </td> |
− | + | <td style="border: 3px solid rgb(29, 16, 3);" | |
− | + | onmouseout="this.bgColor='#ffee1b'" | |
− | + | onmouseover="this.bgColor='#6bb402'" align="center" | |
− | + | bgcolor="#ffee1b" height="30"> | |
− | + | ||
− | + | ||
− | onmouseout="this.bgColor='# | + | |
− | onmouseover="this.bgColor='# | + | |
− | bgcolor="# | + | |
<a href="https://2015.igem.org/Team:San_Andres/Practices" | <a href="https://2015.igem.org/Team:San_Andres/Practices" | ||
− | style="color: rgb(0, 0, 0);"> Human Practices</a></td> | + | style="color: rgb(0, 0, 0);"> Human Practices</a> |
− | <td style="border: | + | </td> |
− | onmouseout="this.bgColor='# | + | <td style="border: 3px solid rgb(29, 16, 3);" |
− | onmouseover="this.bgColor='# | + | onmouseout="this.bgColor='#ffee1b'" |
− | bgcolor="# | + | onmouseover="this.bgColor='#6bb402'" align="center" |
+ | bgcolor="#ffee1b" height="30"> | ||
<a href="https://2015.igem.org/Team:San_Andres/Design" | <a href="https://2015.igem.org/Team:San_Andres/Design" | ||
− | style="color: rgb(0, 0, 0);"> Future Projections</a></td> | + | style="color: rgb(0, 0, 0);"> Future Projections</a> |
− | <td style="border: | + | </td> |
− | onmouseout="this.bgColor='# | + | <td style="border: 3px solid rgb(29, 16, 3);" |
− | onmouseover="this.bgColor='# | + | onmouseout="this.bgColor='#ffee1b'" |
− | bgcolor="# | + | onmouseover="this.bgColor='#6bb402'" align="center" |
+ | bgcolor="#ffee1b" height="30"> | ||
+ | <a href="https://2015.igem.org/Team:San_Andres/Attributions" | ||
+ | style="color: rgb(0, 0, 0);"> Attributions</a> | ||
+ | </td> | ||
+ | <td style="border: 3px solid rgb(29, 16, 3);" | ||
+ | onmouseout="this.bgColor='#ffee1b'" | ||
+ | onmouseover="this.bgColor='#6bb402'" align="center" | ||
+ | bgcolor="#ffee1b" height="30"> | ||
<a href="https://2015.igem.org/Team:San_Andres/Collaborations" | <a href="https://2015.igem.org/Team:San_Andres/Collaborations" | ||
− | style="color: rgb(0, 0, 0);"> Collaborations</a></td> | + | style="color: rgb(0, 0, 0);"> Collaborations</a> |
+ | </td> | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
</table> | </table> | ||
− | |||
<div class="gwd-div-2ed9"></div> | <div class="gwd-div-2ed9"></div> | ||
<div class="gwd-div-7xzo gwd-a-1thu"> | <div class="gwd-div-7xzo gwd-a-1thu"> | ||
− | <h1>Abstract</h1> | + | <h1 style="font-family: Algerian; font-weight: normal;"><big>Abstract</big></h1> |
− | <big>The celiac disease affects 1 in 265 people worldwide and 15% | + | <div style="text-align: justify;"><big |
+ | style="font-family: Cambria;">The celiac | ||
+ | disease affects 1 in 265 people worldwide and 15% | ||
of population in Chile. This in an irreversible autoimmune disease in | of population in Chile. This in an irreversible autoimmune disease in | ||
which due to the presence of genes HLA DQ2 or HLA DQ8 in those | which due to the presence of genes HLA DQ2 or HLA DQ8 in those | ||
Line 624: | Line 742: | ||
from wheat, barley, rye, etc.) cause an inflammation in small intestine | from wheat, barley, rye, etc.) cause an inflammation in small intestine | ||
causing multiple effects in the organism (diarrhea, constipation, porr | causing multiple effects in the organism (diarrhea, constipation, porr | ||
− | absorption, among others) significantly affecting their quatily of life.</big> | + | absorption, among others) significantly affecting their quatily of life.</big><span |
− | < | + | style="font-family: Cambria;"> |
− | < | + | </span><br style="font-family: Cambria;"> |
− | Whereas the majority of the world food contains gluten, we propose a | + | <br style="font-family: Cambria;"> |
+ | <big style="font-family: Cambria;">Whereas the majority of | ||
+ | the world food contains gluten, we | ||
+ | propose a | ||
treatment for those who can't eat gluten, and can do so without | treatment for those who can't eat gluten, and can do so without | ||
problems. In detail, our project involves a system able to degrade | problems. In detail, our project involves a system able to degrade | ||
Line 635: | Line 756: | ||
improve the quality of life of all those reported with celiac disease. | improve the quality of life of all those reported with celiac disease. | ||
People who suffer from gluten intolerance have an adverse reaction to | People who suffer from gluten intolerance have an adverse reaction to | ||
− | gluten proteins found in wheat, barley, and rye products.</big | + | gluten proteins found in wheat, barley, and rye products.</big><span |
− | + | style="font-family: Cambria;"> | |
− | style="font-family: | + | </span><br> |
− | + | ||
− | + | ||
− | + | ||
− | < | + | |
− | + | ||
− | + | ||
</div> | </div> | ||
+ | <big><br> | ||
+ | </big> | ||
+ | <div style="text-align: center;"><img | ||
+ | style="width: 893px; height: 373px;" alt="File:Ex 2.jpg" | ||
+ | src="https://static.igem.org/mediawiki/2015/thumb/9/93/Ex_2.jpg/800px-Ex_2.jpg"><br> | ||
<br> | <br> | ||
+ | <h1 | ||
+ | style="font-family: Algerian; font-weight: normal; text-align: left;"><big><big>Medal</big></big></h1> | ||
+ | <div style="text-align: center;"><big | ||
+ | style="font-family: Cambria;"><big><big>We won a | ||
+ | bronze medal for Chile!!!</big></big><br> | ||
<br> | <br> | ||
+ | </big> | ||
+ | <div style="text-align: center;"><img | ||
+ | style="width: 414px; height: 481px;" alt="File:Bronze.png" | ||
+ | src="https://static.igem.org/mediawiki/2015/thumb/f/f2/Bronze.png/515px-Bronze.png" | ||
+ | srcset="/wiki/images/thumb/f/f2/Bronze.png/772px-Bronze.png 1.5x, /wiki/images/thumb/f/f2/Bronze.png/1029px-Bronze.png 2x"> <img | ||
+ | style="width: 513px; height: 330px;" | ||
+ | alt="File:Chile-153367 640.png" | ||
+ | src="https://static.igem.org/mediawiki/2015/0/09/Chile-153367_640.png"> | ||
+ | <span style="font-family: Cambria;"> | ||
+ | </span><span style="font-family: Cambria;"></span></div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <p class="MsoListParagraph" style="text-indent: -18pt;"> | ||
<br> | <br> | ||
+ | </p> | ||
+ | <p class="MsoListParagraph" style="text-indent: -18pt;"></p> | ||
+ | </div> | ||
<br> | <br> | ||
+ | <a href="https://2015.igem.org/Main_Page" | ||
+ | class="gwd-a-3xpx gwd-a-36ww"> | ||
+ | <img | ||
+ | style="border: 0px solid ; width: 150px; height: 150px; left: 989px; top: 49px;" | ||
+ | alt="" src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" | ||
+ | class="gwd-img-kwqf"></a><a | ||
+ | href="https://igem.org/Team_List?year=2015" | ||
+ | class="gwd-a-3xpx gwd-a-d01x"><img | ||
+ | src="https://static.igem.org/mediawiki/2015/thumb/8/85/Logo_Definitvo.png/654px-Logo_Definitvo.png" | ||
+ | class="gwd-img-zpsn"></a><br> | ||
<br> | <br> | ||
<br> | <br> | ||
<br> | <br> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<br> | <br> | ||
<br> | <br> |
Latest revision as of 23:31, 4 October 2015
Home | Team | Project | Parts | Modeling | Results |
Notebook | Human Practices | Future Projections | Attributions | Collaborations |
Abstract
The celiac
disease affects 1 in 265 people worldwide and 15%
of population in Chile. This in an irreversible autoimmune disease in
which due to the presence of genes HLA DQ2 or HLA DQ8 in those
affected, the consumption of foods containing gluten (all fods derived
from wheat, barley, rye, etc.) cause an inflammation in small intestine
causing multiple effects in the organism (diarrhea, constipation, porr
absorption, among others) significantly affecting their quatily of life.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.
Medal
We won a
bronze medal for Chile!!!